| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/(SICI)1096-8628(19980508)81:3<228::AID-AJMG5>3.0.CO;2-S |
| P698 | PubMed publication ID | 9603610 |
| P2093 | author name string | Z Wang | |
| R Noyes | |||
| R R Crowe | |||
| J Valdes | |||
| T Zoega | |||
| P2860 | cites work | Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey | Q28258215 |
| Co-transcription of the gastrin and cholecystokinin genes with selective translation of gastrin mRNA in a human gastric carcinoma cell line | Q31054831 | ||
| The relationship between panic disorder and major depression. A new family study | Q36753238 | ||
| Biological actions of cholecystokinin | Q40638002 | ||
| Panic disorder in women: a population-based twin study | Q40825835 | ||
| The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description | Q41128285 | ||
| A linkage study of panic disorder | Q41307119 | ||
| Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks | Q41372084 | ||
| Carbon dioxide sensitivity in panic anxiety. Ventilatory and anxiogenic response to carbon dioxide in healthy subjects and patients with panic anxiety before and after alprazolam treatment | Q41381100 | ||
| Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings | Q41936389 | ||
| Structure of human cholecystokinin gene and its chromosomal location | Q48370046 | ||
| CSF cholecystokinin concentrations in patients with panic disorder and in normal comparison subjects | Q48486093 | ||
| Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Preliminary findings. | Q51176483 | ||
| Genetic factors in anxiety disorders. | Q51239731 | ||
| A family study of panic disorder. | Q51239742 | ||
| Age of onset of phobic disorders: A reevaluation | Q51253077 | ||
| Lactate Metabolism in Anxiety Neurosis | Q52128598 | ||
| Limitations of the Application of Fourfold Table Analysis to Hospital Data | Q56503537 | ||
| Panic and panic disorder in the United States | Q57384255 | ||
| Transcriptional regulation of the human cholecystokinin gene: composite action of upstream stimulatory factor, Sp1, and members of the CREB/ATF-AP-1 family of transcription factors | Q70900976 | ||
| Anxiogenic effects of CO2 and hyperventilation in patients with panic disorder | Q72339005 | ||
| Excluding linkage between panic disorder and the gamma-aminobutyric acid beta 1 receptor locus in five Icelandic pedigrees | Q72646367 | ||
| Imipramine antagonism of the panicogenic effects of cholecystokinin tetrapeptide in panic disorder patients | Q72747075 | ||
| P433 | issue | 3 | |
| P921 | main subject | panic disorder | Q741713 |
| cholecystokinin | Q60315441 | ||
| P304 | page(s) | 228-234 | |
| P577 | publication date | 1998-05-01 | |
| P1433 | published in | American Journal of Medical Genetics Part A | Q15755121 |
| P1476 | title | Possible association of a cholecystokinin promotor polymorphism (CCK-36CT) with panic disorder | |
| P478 | volume | 81 |
| Q64797105 | Q64797105 |
| Q57304632 | A Polymorphic Genomic Duplication on Human Chromosome 15 Is a Susceptibility Factor for Panic and Phobic Disorders |
| Q37667843 | Advances in molecular genetics of panic disorder |
| Q77354200 | An association of NAG levels and a mutation of the CCK gene in panic disorder patients |
| Q38590442 | Candidate genes in panic disorder: meta-analyses of 23 common variants in major anxiogenic pathways |
| Q34310158 | Cholecystokinin gene transcription: promoter elements, transcription factors and signaling pathways |
| Q34798306 | Decreased anxiety-like behavior, reduced stress hormones, and neurosteroid supersensitivity in mice lacking protein kinase Cepsilon. |
| Q40445872 | Exploring the association between a cholecystokinin promoter polymorphism (rs1799923) and posttraumatic stress disorder in combat veterans |
| Q33964371 | Function of the C-36 to T polymorphism in the human cholecystokinin gene promoter |
| Q35916405 | Gastrin: old hormone, new functions |
| Q35104041 | Genetic animal models of anxiety |
| Q33946742 | Genetic association analysis of behavioral inhibition using candidate loci from mouse models |
| Q34517497 | Genetic basis of anxiety-like behaviour: a critical review |
| Q48354695 | Identification of a compound short tandem repeat stretch in the 5'-upstream region of the cholecystokinin gene, and its association with panic disorder but not with schizophrenia |
| Q57150578 | Investigation of dopamine receptor (DRD4) and dopamine transporter (DAT) polymorphisms for genetic linkage or association to panic disorder |
| Q51071588 | Neurobiology of anxiety and fear: challenges for genomic science of the new millennium. |
| Q35071526 | Neuroendocrine pharmacology of stress. |
| Q34272451 | Neuronal network of panic disorder: the role of the neuropeptide cholecystokinin |
| Q35600016 | Neuropeptide gene polymorphisms and human behavioural disorders |
| Q77373752 | No association between C-45T polymorphism in the Sp1 binding site of the promoter region of the cholecystokinin gene and alcoholism |
| Q43614660 | No association of CCK and CCK(B) receptor polymorphisms with alcohol dependence |
| Q57150535 | No association or linkage between polymorphisms in the genes encoding cholecystokinin and the cholecystokinin B receptor and panic disorder |
| Q96306681 | Personality neuroscience and psychopathology: should we start with biology and look for neural-level factors? |
| Q79216048 | Polymorphism analysis of HOPA: A candidate gene for schizophrenia |
| Q44448663 | Positive association between panic disorder and polymorphism of the serotonin 2A receptor gene |
| Q51955321 | Possible association of a cholecystokinin promoter variant to schizophrenia. |
| Q48241735 | Regulation of CCK mRNA expression in the rat brain by stress and treatment with sertraline, a selective serotonin re-uptake inhibitor |
| Q95270409 | Some Metatheoretical Principles for Personality Neuroscience |
| Q35009814 | The genetic basis of panic disorder |
| Q34200077 | The genetics of panic disorder |
| Q36917104 | The role of the serotonergic and GABA system in translational approaches in drug discovery for anxiety disorders |
Search more.